TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+2.99%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$671M
AUM Growth
+$671M
(-2.5%)
Cap. Flow
+$89.1M
Cap. Flow
% of AUM
13.28%
Top 10 Holdings %
Top 10 Hldgs %
38.66%
Holding
127
New
38
Increased
28
Reduced
16
Closed
24
Top Buys
| 1 |
Novo Nordisk
NVO
|
$21.5M |
| 2 |
Evolus
EOLS
|
$20.2M |
| 3 |
BLUE
bluebird bio
BLUE
|
$16.7M |
| 4 |
FLG
Flagstar Financial, Inc.
FLG
|
$14.5M |
| 5 |
Adicet Bio
ACET
|
$11.1M |
Top Sells
| 1 |
AnaptysBio
ANAB
|
$13M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$12M |
| 3 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$8.9M |
| 4 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$6.72M |
| 5 |
Cytokinetics
CYTK
|
$5.04M |
Sector Composition
| 1 | Healthcare | 91.26% |
| 2 | Financials | 6.75% |
| 3 | Real Estate | 0.31% |
| 4 | Consumer Discretionary | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASLN
51
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $3.36M | 0.5% |
145,663
+11,540
| +9% | +$266K |
|
52
CVB Financial
CVBF
$2.74B
| $3.34M | 0.5% |
+200,000
| New | +$3.34M |
|
53
Aligos Therapeutics
ALGS
$75.1M
| $2.99M | 0.45% |
136,992
+24,336
| +22% | +$532K |
|
|
ITOS
54
DELISTED
iTeos Therapeutics
ITOS
| $2.95M | 0.44% |
216,700
| – | – |
|
55
Dynavax Technologies
DVAX
$1.19B
| $2.94M | 0.44% |
300,000
| – | – |
|
56
Esperion Therapeutics
ESPR
$490M
| $2.94M | 0.44% |
+1,850,000
| New | +$2.94M |
|
57
Amylyx Pharmaceuticals
AMLX
$877M
| $2.93M | 0.44% |
100,000
| – | – |
|
58
Insmed
INSM
$30.3B
| $2.83M | 0.42% |
166,203
| – | – |
|
59
Arcus Biosciences
RCUS
$1.24B
| $2.7M | 0.4% |
147,920
| – | – |
|
60
ARS Pharmaceuticals
SPRY
$1.08B
| $2.67M | 0.4% |
409,463
| – | – |
|
|
ELEV
61
DELISTED
Elevation Oncology
ELEV
| $2.66M | 0.4% |
1,400,000
+920,146
| +192% | +$1.75M |
|
|
TSVT
62
DELISTED
2seventy bio
TSVT
| $2.55M | 0.38% |
250,000
| – | – |
|
|
EGRX
63
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $2.27M | 0.34% |
80,000
-38,857
| -33% | -$1.1M |
|
64
Bolt Biotherapeutics
BOLT
$9.29M
| $2.26M | 0.34% |
81,378
+61,378
| +307% | +$1.71M |
|
65
Bankunited
BKU
$2.92B
| $2.26M | 0.34% |
+100,000
| New | +$2.26M |
|
|
RXDX
66
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $2.25M | 0.34% |
+21,000
| New | +$2.25M |
|
67
Arvinas
ARVN
$580M
| $2.19M | 0.33% |
80,000
+50,000
| +167% | +$1.37M |
|
|
BLU
68
DELISTED
BELLUS Health Inc.
BLU
| $2.16M | 0.32% |
+300,000
| New | +$2.16M |
|
|
EQC
69
DELISTED
Equity Commonwealth
EQC
| $2.07M | 0.31% |
+100,000
| New | +$2.07M |
|
70
Veritex Holdings
VBTX
$1.86B
| $2.01M | 0.3% |
+110,000
| New | +$2.01M |
|
71
ImmunityBio
IBRX
$2.24B
| $1.99M | 0.3% |
+1,095,795
| New | +$1.99M |
|
|
ALLK
72
DELISTED
Allakos
ALLK
| $1.99M | 0.3% |
447,967
| – | – |
|
73
Biohaven
BHVN
$1.71B
| $1.91M | 0.29% |
140,000
| – | – |
|
74
ServisFirst Bancshares
SFBS
$4.77B
| $1.64M | 0.24% |
+30,000
| New | +$1.64M |
|
75
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $1.37M | 0.2% |
200,000
+84,100
| +73% | +$575K |
|